Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation
Richard J. Johnson(University of Colorado Anschutz Medical Campus), Glenn M. Chertow(Stanford Health Care), Eli A. Stahl(Broad Institute), Tony R. Merriman(University of Alabama at Birmingham), George L. Bakris(Pennsylvania State System of Higher Education), Daniel E. Weiner(Tufts Medical Center), Orson W. Moe(Io Therapeutics (United States)), Miguel A. Lanaspa(University of Colorado Anschutz Medical Campus), Laura Gabriela Sánchez‐Lozada(Instituto Nacional de Cardiología), Claudio Borghi(University of Bologna), David B. Mount(Harvard University), Michel B. Chonchol(University of Colorado Denver), David L. Feldman(Public Policy Institute of California)
Cited by 644
Related Papers
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
|Hypertension|2003|13.3k
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
|New England Journal of Medicine|2004|11.4k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k
Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized Patients
|Journal of the American Society of Nephrology|2005|3.4k